Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10073780 | 0.93 | — | — | |
| SCHEMBL5524685 | 0.93 | — | — | |
| SCHEMBL5528595 | 0.93 | — | — | |
| SCHEMBL35798 | 0.93 | — | — | |
| SCHEMBL30368919 | 0.90 | HSD17B10 (0.60) | HSD17B10MAPK1TDP1TSHRLMNA | |
| Ethylene SCHEMBL8898059 | 0.87 | HSD17B10 (0.57) | HSD17B10MAPK1TDP1TSHRLMNA | |
| Methoxymethane SCHEMBL28415479 | 0.85 | HSD17B10 (0.56) | HSD17B10MAPK1TDP1TSHRLMNA | |
| SCHEMBL23560611 | 0.84 | HSD17B10 (0.62) | HSD17B10MAPK1TDP1TSHRLMNA | |
| SCHEMBL8962559 | 0.84 | HSD17B10 (0.55) | HSD17B10MAPK1TDP1TSHRLMNA | |
| SCHEMBL483498 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 795 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217932-A1 | PYRIDIUM ESTERS | THE PROCTER AND GAMBLE COMPANY | 2024-07-04 | — | — | US | claimed |
| EP-4374698-A1 | PYRIDINIUM ESTERS | The Procter & Gamble Company (US) | 2024-05-29 | — | — | EP | claimed |
| US-20240110132-A1 | POTENTIAL OF HYDROGEN (pH) STABILIZED CLEANING FORMULATIONS | ENVIROX, L.L.C. | 2024-04-04 | — | — | US | claimed |
| US-11940358-B2 | Eosin staining techniques | VENTANA MEDICAL SYSTEMS, INC. (US) | 2024-03-26 | — | — | US | claimed |
| WO-2024058857-A1 | POTENTIAL OF HYDROGEN (PH) STABILIZED CLEANING FORMULATIONS | EnvirOx, LLC (US) | 2024-03-21 | — | — | WO | claimed |
| US-11932769-B2 | Printable flexible overcoat ink compositions | XEROX CORPORATION (US) | 2024-03-19 | — | — | US | claimed |
| EP-4125708-B1 | METHOD FOR MANUFACTURING A GLAZED DENTAL PROSTHESIS | STRAUMANN INST AG (CH) | 2024-02-21 | — | — | EP | claimed |
| US-11859108-B2 | Finishing mediums and finishing suspensions | POSTPROCESS TECHNOLOGIES, INC. (US) | 2024-01-02 | — | — | US | claimed |
| EP-4291614-A1 | CONDUCTIVE CARBON NANOTUBE-SILVER COMPOSITE INK COMPOSITION | Yazaki Corporation (JP) | 2023-12-20 | — | — | EP | claimed |
| WO-2023240102-A1 | ANTIMICROBIAL COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-14 | — | — | WO | claimed |
| US-20020064547-A1 | LIQUID POLYMERIC COMPOSITIONS FOR CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES | MERCK SHARP & DOHME CORP. | 2002-05-30 | — | — | US | claimed |
| US-20020065352-A1 | Drag-reducing polymers and suspensions thereof | CONOCO, INC. | 2002-05-30 | — | — | US | claimed |
| WO-2001034760-A1 | MICROEMULSION CLEANING COMPOSITION | BAKER HUGHES INCORPORATED (US) | 2001-05-17 | — | — | WO | claimed |
| US-6172151-B1 | Nonaqueous drag reducing suspensions | CONOCO INC. | 2001-01-09 | — | — | US | claimed |
| EP-1063942-A1 | LIQUID POLYMERIC COMPOSITIONS FOR CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES | Merck & Co., Inc. (US) | 2001-01-03 | — | — | EP | claimed |
| US-6090860-A | Methods of recycling and compositions used therein | PPG INDUSTRIES OHIO, INC. (US) | 2000-07-18 | — | — | US | claimed |
| US-6054422-A | POLYOXYALKYLENE GLYCOL | PPT RESEARCH, INC. (US) | 2000-04-25 | — | — | US | claimed |
| US-6015495-A | POROUS SUPPORT AND THIN POLYAMIDE FILM FORMED BY INTERFACIAL POLYMERIZATION OF POLYFUNCTIONAL AMINE AND POLYFUNCTIONAL ACYL HALIDE IN MIXED SOLVENT COMPRISING WATER AND POLAR COMPOUND | SAEHAN INDUSTRIES INCORPORATION (KR) | 2000-01-18 | — | — | US | claimed |
| WO-1999047073-A1 | LIQUID POLYMERIC COMPOSITIONS FOR CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES | MERCK & CO., INC. (US) | 1999-09-23 | — | — | WO | claimed |
| US-5637757-A | REACTING TETRABROMOPHTHALIC ANHYDRIDE WITH AN ALCOHOL IN PRESENCE OF A DECARBOXYLATION CATALYST | GREAT LAKES CHEMICAL CORPORATION (US) | 1997-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217932-A1 | PYRIDIUM ESTERS | C5, CBR3, CHRM1 | HSD17B10 543/4885MAPK1 2902/4885TDP1 3910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.